Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Comparison of Innovator and Generic Tacrolimus in Kidney Transplant Patients Receiving CYP3A Boosters
TCTR20251015001Phase 1Completed
- Sponsor
- The Kidney Foundation of Thailand
- Start
- Nov 2025
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of tacrolimus in Kidney allograft status (RTx) (2 arms), sponsored by The Kidney Foundation of Thailand. Started Nov 2025; status: completed.
02
Drugs
tacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on TCTR20251015001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251015001.